跳至主要内容
临床试验/NCT02294097
NCT02294097Unknown不适用

The Outcomes of Protocol-Specified Modification of Immunosuppression Directed to Histological Diagnosis by Surveillance Protocol Biopsy

Chulalongkorn University2 个研究点 分布在 1 个国家目标入组 100 人开始时间: 2014年11月最近更新:
适应症

试验速览

阶段
不适用
入组人数
100
试验地点
2
主要终点
Renal function

研究概览

简要总结

The risk-benefit of surveillance-protocol biopsy (SPBx) in kidney transplantation remains unclear. The study aims to compare outcomes of recipients with SPBx approach to recipients with standard approach which allograft biopsy was performed only when indicated.

详细描述

The present randomized-controlled trial in kidney transplant patients aims to compare the outcomes and complications between who underwent immunosuppessive drug modification under surveillance-protocol biopsy and who underwent immunosuppressive drug modification following tough level only.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Prevention
盲法
Single (Outcomes Assessor)

入排标准

年龄范围
17 Years 至 70 Years(Child, Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • All kidney transplant recipients underwent transplantation at Chulalongkorn University

排除标准

  • Pregnancy
  • Recipients who cannot withhold aspirin, clopidogrel, warfarin, etc.
  • Non-cooperated recipients

结局指标

主要结局

Renal function

时间窗: 24 months

24 h-CrCl

次要结局

  • Renal pathology(24 months)
  • Complications(immediate, 1 month)

研究者

申办方类型
Other
责任方
Principal Investigator
主要研究者

Wiwat Chancharoenthana

Chulalongkorn University

Chulalongkorn University

研究点 (2)

Loading locations...

相似试验